Breaking
Wednesday, July 8, 2026

News

🇺🇸 FDA Page 50

Latest pharmaceutical news, drug approvals, and FDA regulatory updates

Showing 589–600 of 807 articles

High impact NewsApr 22, 2026

Excipient World 2026: Trends in Drug Delivery & Formulation

general · 4 min

Dr. Sarah Mitchell
Critical impact NewsApr 22, 2026

Unveiling the 4th Annual COG: What to Expect (If It Exists)

general · 4 min

Dr. Sarah Mitchell
High impact NewsApr 22, 2026

Pharma Compliance Congress 2026: Enforcement Trends & DOJ Insights

regulatory · 4 min

Dr. Sarah Mitchell
Critical impact NewsApr 22, 2026

AACR 2026: Pembrolizumab Bowel Cancer Success, Moderna Melanoma Data

oncology · 7 min

Dr. Sarah Mitchell
Critical impact NewsApr 22, 2026

AACR 2026: Myocarditis Risk, KRAS Inhibitors, mRNA Advances

oncology · 7 min

Dr. Sarah Mitchell
High impact NewsApr 22, 2026

ACRP 2026: Immunology Clinical Research Trends to Watch

immunology · 3 min

Dr. Sarah Mitchell
High impact NewsApr 22, 2026

Francis Medical's Vanquish System Performs First Commercial Prostate Ablation Procedure in Midwest

2 min

James Chen, PharmD
High impact NewsApr 22, 2026

Aquestive Therapeutics Faces FDA Deficiencies for Anaphylm Drug Application, Class Action Lawsuit Filed

Anaphylaxis treatment · 3 min

Dr. Sarah Mitchell
High impact NewsApr 22, 2026

Efemoral Medical's Bioresorbable Scaffold Achieves 97% Patency Rate in Peripheral Artery Disease Trial

Cardiovascular - Peripheral Artery Disease · 3 min

James Chen, PharmD
Critical impact NewsApr 22, 2026

Kyverna's Miv-cel Shows Breakthrough Results in Stiff Person Syndrome Trial, Potentially First Approved Treatment

Neurology - Stiff Person Syndrome · 3 min

James Chen, PharmD
High impact NewsApr 22, 2026

InVera Medical Reports 90% Vein Closure Success Rate in 12-Month Chronic Venous Disease Trial

2 min

James Chen, PharmD
High impact NewsApr 22, 2026

REVA Medical's MOTIV Sirolimus-Eluting Scaffold Shows Superior Results in Critical Limb Ischemia Trial

3 min

James Chen, PharmD